The role of p53 in nitric oxide-induced cardiomyocyte cell death

DNA and Cell Biology

Volumn 26, Issue 7, 2007, Pages 465-475

  Klassen, Shaun S ^a   Rabkin, Simon W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; CYTOCHROME C; DNA FRAGMENT; DOXORUBICIN; NITRIC OXIDE; PIFITHRIN ALPHA; PROTEIN P53; S NITROSOGLUTATHIONE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL LYSATE; CELL NUCLEUS; CELL STRUCTURE; CELL VIABILITY; CHANNEL GATING; COMET ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; EMBRYO; HEART MUSCLE CELL; IMMUNOCYTOCHEMISTRY; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; WESTERN BLOTTING;

ANIMALS; CELL CULTURE TECHNIQUES; CELL DEATH; CHICK EMBRYO; HEART; MUSCLE CELLS; MYOCARDIUM; NITRIC OXIDE; NITRIC OXIDE DONORS; S-NITROSOGLUTATHIONE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34547107079     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2007.0576     Document Type: Article

References (60)

1. ARIMA, Y., NITTA, M., KUNINAKA, S., ZHANG, D., FUJIWARA, T., TAYA, Y., NAKAO, M., and SAYA, H. (2005). Transcriptional blockade induces p53-dependent apoptosis associated with translocation of p53 to mitochondria. J. Biol. Chem. 280, 19166-19176.
2. BROCKHAUS, F., and BRUNE, B. (1999). p53 accumulation in apoptotic macrophages is an energy demanding process that precedes cytochrome c release in response to nitric oxide. Oncogene 18, 6403-6410.
3. BURNEY, S., CAULFIELD, J.L., NILES, J.C., WISHNOK, J.S., and TANNENBAUM, S.R. (1999). The chemistry of DNA damage from nitric oxide and peroxynitrite. Mutat. Res. 424, 37-49.
4. CULMSEE, C., ZHU, X., YU, Q.S., CHAN, S.L., CAMANDOLA, S., GUO, Z., GREIG, N.H., and MATTSON, M.P. (2001). A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid beta-peptide. J. Neurochem. 77, 220-228.
5. DASGUPTA, G., and MOMAND, J. (1997). Geldanamycin prevents nuclear translocation of mutant p53. Exp. Cell Res. 237, 29-37.
6. EL GIBALY, A.M., SCHEUER, C., MENGER, M.D., and VOLLMAR, B. (2004). Improvement of rat liver graft quality by pifithrin-alpha-mediated inhibition of hepatocyte necrapoptosis. Hepatology 39, 1553-1562.
7. FERNANDEZ, P.A., ROTELLO, R.J., RANGINI, Z., DOUPE, A., DREXLER, H.C., and YUAN, J. (1994). Expression of a specific marker of avian programmed cell death in both apoptosis and necrosis. Proc. Natl. Acad. Sci. USA 91, 8641-8645.
8. GOMEZ-LAZARO, M., FERNANDEZ-GOMEZ, F.J., and JORDAN, J. (2004). p53: twenty five years understanding the mechanism of genome protection. J. Physiol. Biochem. 60, 287-307.
9. GOPALAKRISHNA, P., and KHAR, A. (1995). Comet assay to measure DNA damage in apoptotic cells. J. Biochem. Biophys. Methods 30, 69-73.
10. HALDAR, S., NEGRINI, M., MONNE, M., SABBIONI, S., and CROCE, C.M. (1994). Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res. 54, 2095-2097.
11. HOAGLAND, M.S., HOAGLAND, E.M., and SWANSON, H.I. (2005). The p53 inhibitor pifithrin-alpha is a potent agonist of the aryl hydrocarbon receptor. J. Pharmacol. Exp. Ther. 314, 603-610.
12. HOMER, C., KNIGHT, D.A., HANANEIA, L., SHEARD, P., RISK, J., LASHAM, A., ROYDS, J.A., and BRAITHWAITE, A.W. (2005). Y-box factor YB1 controls p53 apoptotic function. Oncogene 24, 8314-8325.
13. JOZA, N., KROEMER, G., and PENNINGER, J.M. (2002). Genetic analysis of the mammalian cell death machinery. Trends Genet. 18, 142-149.
14. KAJI, A., ZHANG, Y., NOMURA, M., BODE, A.M., MA, W.Y., SHE, Q.B., and DONG, Z. (2003). Pifithrin-alpha promotes p53-mediated apoptosis in JB6 cells. Mol. Carcinog. 37, 138-148.
15. KASTAN, M.B., ONYEKWERE, O., SIDRANSKY, D., VOGELSTEIN, B., and CRAIG, R.W. (1991). Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51, 6304-6311.
16. KERN, S.E., KINZLER, K.W., BRUSKIN, A., JAROSZ, D., FRIEDMAN, P., PRIVES, C., and VOGELSTEIN, B. (1991). Identification of p53 as a sequence-specific DNA-binding protein. Science 252, 1708-1711.
17. KIM, Y.M., KIM, T.H., SEOL, D.W., TALANIAN, R.V., and BILLIAR, T.R. (1998). Nitric oxide suppression of apoptosis occurs in association with an inhibition of Bcl-2 cleavage and cytochrome c release. J. Biol. Chem. 273, 31437-31441.
18. KOMAROV, P.G., KOMAROVA, E.A., KONDRATOV, R.V., CHRISTOV-TSELKOV, K., COON, J.S., CHERNOV, M.V., and GUDKOV, A.V. (1999). A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 285, 1733-1737.
19. KOMAROVA, E.A., NEZNANOV, N., KOMAROV, P.G., CHERNOV, M.V., WANG, K., and GUDKOV, A.V. (2003). p53 inhibitor pifithrin alpha can suppress heat shock and glucocorticoid signaling pathways. J. Biol. Chem. 278, 15465-15468.
20. KONG, J.Y., and RABKIN, S.W. (2000). Palmitate-induced apoptosis in cardiomyocytes is mediated through alterations in mitochondria: prevention by cyclosporin A. Biochim. Biophys. Acta 1485, 45-55.
21. KONG, J.Y., KLASSEN, S.S., and RABKIN, S.W. (2005). Ceramide activates a mitochondrial p38 mitogen-activated protein kinase: a potential mechanism for loss of mitochondrial transmembrane potential and apoptosis. Mol. Cell. Biochem. 278, 39-51.
22. LANE, D.P. (1992). Cancer. p53, guardian of the genome. Nature 358, 15-16.
23. LEIST, M., SINGLE, B., NAUMANN, H., FAVA, E., SIMON, B., KUHNLE, S., and NICOTERA, P. (1999). Nitric oxide inhibits execution of apoptosis at two distinct ATP-dependent steps upstream and downstream of mitochondrial cytochrome c release. Biochem. Biophys. Res. Commun. 258, 215-221.
24. LI, P.F., DIETZ, R., and VON HARSDORF, R. (1999). p53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2. EMBO J. 18, 6027-6036.
25. LINDAHL, T., and ANDERSSON, A. (1972). Rate of chain breakage at apurinic sites in double-stranded deoxyribonucleic acid. Biochemistry 11, 3618-3623.
26. LIU, X., CHUA, C.C., GAO, J., CHEN, Z., LANDY, C.L., HAMDY, R., and CHUA, B.H. (2004). Pifithrin-alpha protects against doxorubicin-induced apoptosis and acute cardiotoxicity in mice. Am. J. Physiol. Heart Circ. Physiol. 286, H933-H939.
27. LIU, X., KIM, C.N., YANG, J., JEMMERSON, R., and WANG, X. (1996). Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86, 147-157.
28. MARCHENKO, N.D., ZAIKA, A., and MOLL, U.M. (2000). Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling. J. Biol. Chem. 275, 16202-16212.
29. MELINO, G., CATANI, M.V., CORAZZARI, M., GUERRIERI, P., and BERNASSOLA, F. (2000). Nitric oxide can inhibit apoptosis or switch it into necrosis. Cell. Mol. Life Sci. 57, 612-622.
30. MESSMER, U.K., ANKARCRONA, M., NICOTERA, P., and BRUNE, B. (1994). p53 expression in nitric oxide-induced apoptosis. FEBS Lett. 355, 23-26.
31. MIHARA, M., ERSTER, S., ZAIKA, A., PETRENKO, O., CHITTENDEN, T., PANCOSKA, P., and MOLL, U.M. (2003). p53 has a direct apoptogenic role at the mitochondria. Mol. Cell 11, 577-590.
32. MIYASHITA, T., KRAJEWSKI, S., KRAJEWSKA, M., WANG, H.G., LIN, H.K., LIEBERMANN, D.A., HOFFMAN, B., and REED, J.C. (1994). Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9, 1799-1805.
33. MORONI, M.C., HICKMAN, E.S., LAZZERINI, D.E., CAPRARA, G., COLLI, E., CECCONI, F., MULLER, H., and HELIN, K. (2001). Apaf-1 is a transcriptional target for E2F and p53. Nat. Cell Biol. 3, 552-558.
34. NAKANO, K., and VOUSDEN, K.H. (2001). PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell 7, 683-694.
35. NEMAJEROVA, A., WOLFF, S., PETRENKO, O., and MOLL, U.M. (2005). Viral and cellular oncogenes induce rapid mitochondrial translocation of p53 in primary epithelial and endothelial cells early in apoptosis. FEBS Lett. 579, 6079-6083.
36. OSTLING, O., and JOHANSON, K.J. (1984). Microelectrophoretic study of radiation-induced DNA damages in individual mammalian cells. Biochem. Biophys. Res. Commun. 123, 291-298.
37. PINSKY, D.J., AJI, W., SZABOLCS, M., ATHAN, E.S., LIU, Y., YANG, Y.M., KLINE, R.P., OLSON, K.E., and CANNON, P.J. (1999). Nitric oxide triggers programmed cell death (apoptosis) of adult rat ventricular myocytes in culture. Am. J. Physiol. 277, H1189-H1199.
38. RABKIN, S.W., and KONG, J.Y. (2000). Nitroprusside induces cardiomyocyte death: interaction with hydrogen peroxide. Am. J. Physiol. Heart Circ. Physiol. 279, H3089-H3100.
39. REGULA, K.M., and KIRSHENBAUM, L.A. (2005). Apoptosis of ventricular myocytes: a means to an end. J. Mol. Cell. Cardiol. 38, 3-13.
40. SANSOME, C., ZAIKA, A., MARCHENKO, N.D., and MOLL, U.M. (2001). Hypoxia death stimulus induces translocation of p53 protein to mitochondria. Detection by immunofluorescence on whole cells. FEBS Lett. 488, 110-115.
41. SAX, J.K., FEI, P., MURPHY, M.E., BERNHARD, E., KORSMEYER, S.J., and EL DEIRY, W.S. (2002). BID regulation by p53 contributes to chemosensitivity. Nat. Cell Biol. 4, 842-849.
42. SCHAFER, T., SCHEUER, C., ROEMER, K., MENGER, M.D., and VOLLMAR, B. (2003). Inhibition of p53 protects liver tissue against endotoxin-induced apoptotic and necrotic cell death. FASEB J. 17, 660-667.
43. SCHNEIDERHAN, N., BUDDE, A., ZHANG, Y., and BRUNE, B. (2003). Nitric oxide induces phosphorylation of p53 and impairs nuclear export. Oncogene 22, 2857-2868.
44. SENGUPTA, S., and HARRIS, C.C. (2005). p53: traffic cop at the crossroads of DNA repair and recombination. Nat. Rev. Mol. Cell Biol. 6, 44-55.
45. SHIMOJO, T., HIROE, M., ISHIYAMA, S., ITO, H., NISHIKAWA, T., and MARUMO, F. (1999). Nitric oxide induces apoptotic death of cardiomyocytes via a cyclic-GMP-dependent pathway. Exp. Cell Res. 247, 38-47.
46. SHIZUKUDA, Y., MATOBA, S., MIAN, O.Y., NGUYEN, T., and HWANG, P.M. (2005). Targeted disruption of p53 attenuates doxorubicin-induced cardiac toxicity in mice. Mol. Cell. Biochem. 273, 25-32.
47. SINGH, N.P., MCCOY, M.T., TICE, R.R., and SCHNEIDER, E.L. (1988). A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 175, 184-191.
48. SMITH, M.L., CHEN, I.T., ZHAN, Q., O'CONNOR, P.M., and FORNACE, A.J., JR. (1995). Involvement of the p53 tumor suppressor in repair of u.v.-type DNA damage. Oncogene 10, 1053-1059.
49. STEFANELLI, C., PIGNATTI, C., TANTINI, B., STANIC, I., BONAVITA, F., MUSCARI, C., GUARNIERI, C., CLO, C., and CALDARERA, C.M. (1999). Nitric oxide can function as either a killer molecule or an antiapoptotic effector in cardiomyocytes. Biochim. Biophys. Acta 1450, 406-413.
50. STROSZNAJDER, R.P., JESKO, H., BANASIK, M., and TANAKA, S. (2005). Effects of p53 inhibitor on survival and death of cells subjected to oxidative stress. J. Physiol. Pharmacol. 56 Suppl 4, 215-221.
51. TEJEDO, J., BERNABE, J.C., RAMIREZ, R., SOBRINO, F., and BEDOYA, F.J. (1999). NO induces a cGMP-independent release of cytochrome c from mitochondria which precedes caspase 3 activation in insulin producing RINm5F cells. FEBS Lett. 459, 238-243.
52. TIAN, B., LIU, J., BITTERMAN, P.B., and BACHE, R.J. (2002). Mechanisms of cytokine induced NO-mediated cardiac fibroblast apoptosis. Am. J. Physiol. Heart Circ. Physiol. 283, H1958-H1967.
53. TOMLINSON, C.W., GODIN, D.V., and RABKIN, S.W. (1985). Adriamycin cardiomyopathy: implications of cellular changes in a canine model with mild impairment of left ventricular function. Biochem. Pharmacol. 34, 4033-4041.
54. TSANG, M.Y., COWIE, S.E., and RABKIN, S.W. (2004). Palmitate increases nitric oxide synthase activity that is involved in palmitate-induced cell death in cardiomyocytes. Nitric Oxide 10, 11-19.
55. UCHIYAMA, T., OTANI, H., OKADA, T., NINOMIYA, H., KIDO, M., IMAMURA, H., NOGI, S., and KOBAYASHI, Y. (2002). Nitric oxide induces caspase-dependent apoptosis and necrosis in neonatal rat cardiomyocytes. J. Mol. Cell. Cardiol. 34, 1049-1061.
56. WANG, G., LIEM, D.A., VONDRISKA, T.M., HONDA, H.M., KORGE, P., PANTALEON, D.M., QIAO, X., WANG, Y., WEISS, J.N., and PING, P. (2005). Nitric oxide donors protect murine myocardium against infarction via modulation of mitochondrial permeability transition. Am. J. Physiol. Heart Circ. Physiol. 288, H1290-H1295.
57. WEISS, J.N., KORGE, P., HONDA, H.M., and PING, P. (2003). Role of the mitochondrial permeability transition in myocardial disease. Circ. Res. 93, 292-301.
58. WINK, D.A., and MITCHELL, J.B. (1998). Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic. Biol. Med. 25, 434-456.
59. YU, J., and ZHANG, L. (2005). The transcriptional targets of p53 in apoptosis control. Biochem. Biophys. Res. Commun. 331, 851-858.
60. ZAMZAMI, N., SUSIN, S.A., MARCHETTI, P., HIRSCH, T., GOMEZ-MONTERREY, I., CASTEDO, M., and KROEMER, G. (1996). Mitochondrial control of nuclear apoptosis. J. Exp. Med. 183, 1533-1544.